Combining Topology and Sequence Design for the Discovery of Potent Antimicrobial Peptide Dendrimers against Multidrug-Resistant Pseudomonas aeruginosa
Multidrug‐resistant opportunistic bacteria, such as Pseudomonas aeruginosa, represent a major public health threat. Antimicrobial peptides (AMPs) and related peptidomimetic systems offer an attractive opportunity to control these pathogens. AMP dendrimers (AMPDs) with high activity against multidrug...
Saved in:
Published in | Angewandte Chemie Vol. 126; no. 47; pp. 13041 - 13045 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
17.11.2014
WILEY‐VCH Verlag Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Multidrug‐resistant opportunistic bacteria, such as Pseudomonas aeruginosa, represent a major public health threat. Antimicrobial peptides (AMPs) and related peptidomimetic systems offer an attractive opportunity to control these pathogens. AMP dendrimers (AMPDs) with high activity against multidrug‐resistant clinical isolates of P. aeruginosa and Acinetobacter baumannii were now identified by a systematic survey of the peptide sequences within the branches of a distinct type of third‐generation peptide dendrimers. Combined topology and peptide sequence design as illustrated here represents a new and general strategy to discover new antimicrobial agents to fight multidrug‐resistant bacterial pathogens.
Multiresistente Bakterien wie Pseudomonas aeruginosa und Acinetobacter baumannii stellen eine Bedrohung für die öffentliche Gesundheit dar. Das kombinierte Design von Topologie und Aminosäuresequenz führte zu neuen antimikrobiellen Peptid‐Dendrimeren mit hoher Aktivität gegen diese Pathogene, was einen neuen und allgemeinen Ansatz zur Entdeckung antimikrobieller Wirkstoffe darstellt. |
---|---|
Bibliography: | This work was supported financially by the University of Bern, the Swiss National Science Foundation, the European Marie Curie Initial Training Network BioChemLig, and Swiss TransMed. Swiss National Science Foundation University of Bern ArticleID:ANGE201409270 Swiss TransMed istex:0B0331BBB8BDF87D0CD1731E144E95AEF9D3BB90 ark:/67375/WNG-D91VVM6L-M European Marie Curie Initial Training Network BioChemLig ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0044-8249 1521-3757 |
DOI: | 10.1002/ange.201409270 |